Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
The Lancet. Oncology|June 2, 2012
Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?Zachary S Zumsteg, Michael J Zelefsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After ProstatectomyZachary S Zumsteg, Timothy J Daskivich, Howard M Sandler
European Urology Oncology|August 15, 2019
Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the BladderDevin N Patel, Michael Luu, Zachary S Zumsteg, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Translational and clinical implications of the genetic landscape of prostate cancerDaniel E Spratt, Zachary S Zumsteg, Felix Y Feng, et al.
JAMA Oncology|December 14, 2018
Parallels Between Low-Risk Prostate Cancer and Thyroid Cancer: A ReviewAllen S Ho, Timothy J Daskivich, Wendy L Sacks, et al.
Cancers of the Head & Neck|May 17, 2019
Oral and dental health in head and neck cancer survivorsFiroozeh Samim, Joel B Epstein, Zachary S Zumsteg, et al.
Urologic Oncology|May 29, 2021
Outcomes with brachytherapy based dose escalation for gleason 8 versus 9-10 prostate cancer: An NCDB analysisJohn David, Michael Luu, Diana Lu, et al.
Journal of Neurological Surgery Reports|November 29, 2023
Proton Therapy for Skull Base ChondrosarcomaDennis M Tang, Raffaello M Cutri, Arthur W Wu, et al.
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Power feasibility of implantable digital spike-sorting circuits for neural prosthetic systemsZachary S Zumsteg, Rizwan E Ahmed, Gopal Santhanam, et al.
European Urology|January 5, 2013
Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortalityDaniel E Spratt, Chi Zhang, Zachary S Zumsteg, et al.
Pageof 11